Raymond James & Associates’s Parkway, Inc. PKY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-11,269
Closed -$258K 3544
2017
Q2
$258K Sell
11,269
-2,127
-16% -$42.9K ﹤0.01% 2828
2017
Q1
$266K Sell
13,396
-2,729
-17% -$57K ﹤0.01% 2771
2016
Q4
$359K Sell
16,125
-2,514
-13% -$47.5K ﹤0.01% 2530
2016
Q3
$317K Sell
18,639
-12
-0.1% -$209 ﹤0.01% 2586
2016
Q2
$312K Sell
18,651
-3,000
-14% -$49.6K ﹤0.01% 2393
2016
Q1
$339K Sell
21,651
-7,201
-25% -$99.9K ﹤0.01% 2253
2015
Q4
$451K Sell
28,852
-7,575
-21% -$124K ﹤0.01% 2037
2015
Q3
$567K Sell
36,427
-9,323
-20% -$157K ﹤0.01% 1870
2015
Q2
$798K Sell
45,750
-6,193
-12% -$106K ﹤0.01% 1835
2015
Q1
$901K Buy
51,943
+26,046
+101% +$464K ﹤0.01% 1726
2014
Q4
$476K Sell
25,897
-4,003
-13% -$76.3K ﹤0.01% 1965
2014
Q3
$562K Buy
29,900
+1,175
+4% +$24.1K ﹤0.01% 1805
2014
Q2
$593K Sell
28,725
-12,216
-30% -$237K ﹤0.01% 1762
2014
Q1
$747K Buy
40,941
+27,401
+202% +$494K 0.01% 1587
2013
Q4
$261K Sell
13,540
-3,604
-21% -$64.7K ﹤0.01% 1888
2013
Q3
$305K Buy
+17,144
New +$300K ﹤0.01% 1786

Other funds holding PKY

Raymond James & Associates's PKY Position: Q3 2017 in Review

Raymond James & Associates sold out of Parkway, Inc. (PKY) in Q3 2017, closing a stake of 11,269 shares — an estimated $258K sold.

Raymond James & Associates first reported a position in PKY in Q3 2013 and held it in 16 quarters. The position peaked at $901K in Q1 2015. 145 funds tracked by Wall St. Rank hold PKY as of Q3 2017.

  • Raymond James & Associates reported no remaining Parkway, Inc. position as of Q3 2017 after selling out during the quarter.
  • Raymond James & Associates sold 11,269 Parkway, Inc. shares in Q3 2017, an estimated $258K.
  • Raymond James & Associates first reported a position in Parkway, Inc. in Q3 2013 and held it in 16 quarters.
  • Raymond James & Associates's Parkway, Inc. position peaked at $901K in Q1 2015.
  • 145 funds tracked by Wall St. Rank held Parkway, Inc. as of Q3 2017.

Based on Raymond James & Associates's 13F filing for Q3 2017, filed 13 Nov 2017.